Abstract
The recent increase in the number of patients taking opioids chronically for pain has not yielded the expected benefits in reduction of symptoms and improved function. Chronic pain patients typically respond well initially to opioid medications, but regular use is associated with adverse psychological and physical effects. Patients with significant psychiatric comorbidity and substance use issues are more likely to stay on opioids and to receive higher doses. In the common rheumatological conditions of fibromyalgia and osteoarthritis, opioid treatment is of limited benefit because of lack of efficacy and prominent side effects. Chronic opioid therapy may be more usefully regarded as a form of comfort care, reserved for those patients who have exhausted other treatments and prospects of recovery.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 1986;25:171–86.
Roth SH, Fleischmann RM, Burch FX, et al. Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation. Arch Intern Med. 2000;160:853–60.
Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18:1166–75.
Singh JA, Lewallen D. Age, gender, obesity, and depression are associated with patient-related pain and function outcome after revision total hip arthroplasty. Clin Rheumatol. 2009;28:1419–30.
Martin BC, Fan MY, Edlund MJ, et al. Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med. 2011;26:1450–7.
Ballantyne J, Shin N. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24:469–78.
Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589–94.
Turner JA, Franklin G, Fulton-Kehoe D, et al. ISSLS prize winner: early predictors of chronic work disability: a prospective, population-based study of workers with back injuries. Spine (Phila Pa 1976). 2008;33:2809–18.
Sjogren P, Thomsen AB, Olsen AK. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manage. 2000;19:100–8.
Kidner CL, Mayer TG, Gatchel RJ. Higher opioid doses predict poorer functional outcome in patients with chronic disabling occupational musculoskeletal disorders. J Bone Joint Surg Am. 2009;91:919–27.
Hannan MT, Felson DT, Pincus T. Analysis of the discordance between radiographic changes and knee pain in osteoarthritis of the knee. J Rheumatol. 2000;27:1513–7.
Caldwell JR, Hale ME, Boyd RE, et al. Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial. J Rheumatol. 1999;26:862–9.
American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43:1905–15.
Jordan KM, Arden NK, Doherty M, et al. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62:1145–55.
Nuesch E, Rutjes AW, Husni E, et al: Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009, CD003115.
Ngian GS, Guymer EK, Littlejohn GO. The use of opioids in fibromyalgia. Int J Rheum Dis. 2011;14:6–11.
Fitzcharles MA, Ste-Marie PA, Gamsa A, et al. Opioid use, misuse, and abuse in patients labeled as fibromyalgia. Am J Med. 2011;124:955–60.
• Crofford LJ. Adverse effects of chronic opioid therapy for chronic musculoskeletal pain. Nat Rev Rheumatol. 2010;6:191–7. Excellent review of the potential disadvantages of chronic opioid administration.
Harris RE, Clauw DJ, Scott DJ, et al. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci: Off J Soc Neurosci. 2007;27:10000–6.
• Edlund MJ, Martin BC, Devries A, et al. Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain. 2010;26:1–8. This article clearly delineates the phenomenon of “adverse selection” in opioid treatment.
Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain: Off J Am Pain Soc. 2009;10:113–30.
Sullivan MD. Who gets high-dose opioid therapy for chronic non-cancer pain? Pain. 2010;151:567–8.
Stein MB, McQuaid JR, Pedrelli P, et al. Posttraumatic stress disorder in the primary care medical setting. Gen Hosp Psychiatry. 2000;22:261–9.
Schwartz AC, Bradley R, Penza KM, et al. Pain medication use among patients with posttraumatic stress disorder. Psychosomatics. 2006;47:136–42.
Mills KL, Teesson M, Ross J, et al. The costs and outcomes of treatment for opioid dependence associated with posttraumatic stress disorder. Psychiatr Serv. 2005;56:940–5.
Seal KH, Shi Y, Cohen G, et al. Association of mental health disorders with prescription opioids and high-risk opioid use in US veterans of Iraq and Afghanistan. JAMA. 2012;307:940–7.
Saunders C. The treatment of intractable pain in terminal cancer. Proc Roy Soc Med. 1963;56:195–7.
Saunders C. A personal therapeutic journey. BMJ. 1996;313:1599–601.
Eisenberger NI. The neural bases of social pain: evidence for shared representations with physical pain. Psychosom Med. 2012;74:126–35.
Wasan AD, Butler SF, Budman SH, et al. Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain. 2007;23:307–15.
• Jamison RN, Edwards RR, Liu X, et al: Relationship of Negative Affect and Outcome of an Opioid Therapy Trial Among Low Back Pain Patients. Pain Pract 2012. Evidence-based examination of the vital role of psychological well-being in pain treatment.
Merlin JS, Childers J, Arnold RM: Chronic Pain in the Outpatient Palliative Care Clinic. The American journal of hospice & palliative care 2012,
Rabow MW, Pantilat SZ, Kerr K, et al. The intersection of need and opportunity: assessing and capitalizing on opportunities to expand hospital-based palliative care services. J Palliat Med. 2010;13:1205–10.
Portenoy RK. Appropriate use of opioids for persistent non-cancer pain. Lancet. 2004;364:739–40.
Billings JA. What is palliative care? J Palliat Med. 1998;1:73–81.
Disclosure
Dr Sullivan has served as a consultant for Janssen Pharmaceutica and has received grant support from Pfizer, Covidien, and Endo. Drs Krashin and Ballantyne reported no potential conflicts of interest relevant to this article.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Chronic Pain
Rights and permissions
About this article
Cite this article
Krashin, D., Sullivan, M. & Ballantyne, J. What Are We Treating with Chronic Opioid Therapy?. Curr Rheumatol Rep 15, 311 (2013). https://doi.org/10.1007/s11926-012-0311-1
Published:
DOI: https://doi.org/10.1007/s11926-012-0311-1